Navicare Biotech Co., Ltd.

NT$49.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:8472Consumer Disc
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 4.30%
Div yield —
ROE (4.32%)
Internet Retail
Beta (5Y) (0.11)
PE TTM —
TSR TTM (37.02%)
Mkt cap NT$869.1M
ROIC (4.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$61
24.83%
(56.22%)
Hold 4|5|7|4|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.76
0.72
0.80
0.77
12.03%
9.88%
14.89%
1.47%
RevenueNT$M
48.34
48.31
46.90
48.12
13.46%
10.31%
7.63%
4.86%
Peers (US$26.25M)
Cap (US$)
PE
56.00M
17.44x
30.76M
—
25.14M
—
Capital
TTM
5Y
10Y
Leveragex
0.829
0.646
0.578
EBIT/Intx
5.051
0.230
0.251
Own earn%
(146.71)
(58.14)
(33.63)
Sh yield%
33.32
18.43
18.51
Owners
Insiders/Inst%
4.99
84.97
Short interest%
4.00
SBC / revenue%
3.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
15–18
$1 testx
0.0
Incr. ROIC%
1